1502 related articles for article (PubMed ID: 25079328)
1. Alterations of the human gut microbiome in liver cirrhosis.
Qin N; Yang F; Li A; Prifti E; Chen Y; Shao L; Guo J; Le Chatelier E; Yao J; Wu L; Zhou J; Ni S; Liu L; Pons N; Batto JM; Kennedy SP; Leonard P; Yuan C; Ding W; Chen Y; Hu X; Zheng B; Qian G; Xu W; Ehrlich SD; Zheng S; Li L
Nature; 2014 Sep; 513(7516):59-64. PubMed ID: 25079328
[TBL] [Abstract][Full Text] [Related]
2. Decompensated cirrhosis and microbiome interpretation.
Bajaj JS; Betrapally NS; Gillevet PM
Nature; 2015 Sep; 525(7569):E1-2. PubMed ID: 26381988
[No Abstract] [Full Text] [Related]
3. Cirrhosis and dysbiosis: New insights from next-generation sequencing.
Gorham J; Gleeson M
Hepatology; 2016 Jan; 63(1):336-8. PubMed ID: 26313376
[No Abstract] [Full Text] [Related]
4. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples.
Korem T; Zeevi D; Suez J; Weinberger A; Avnit-Sagi T; Pompan-Lotan M; Matot E; Jona G; Harmelin A; Cohen N; Sirota-Madi A; Thaiss CA; Pevsner-Fischer M; Sorek R; Xavier R; Elinav E; Segal E
Science; 2015 Sep; 349(6252):1101-1106. PubMed ID: 26229116
[TBL] [Abstract][Full Text] [Related]
5. Qin et al. reply.
Qin N; Le Chatelier E; Guo J; Prifti E; Li L; Ehrlich SD
Nature; 2015 Sep; 525(7569):E2-3. PubMed ID: 26381989
[No Abstract] [Full Text] [Related]
6. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health.
Jia B; Park D; Hahn Y; Jeon CO
Gut Microbes; 2020 Sep; 11(5):1300-1313. PubMed ID: 32329665
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
[TBL] [Abstract][Full Text] [Related]
8. Gene-level metagenomic architectures across diseases yield high-resolution microbiome diagnostic indicators.
Tierney BT; Tan Y; Kostic AD; Patel CJ
Nat Commun; 2021 May; 12(1):2907. PubMed ID: 34006865
[TBL] [Abstract][Full Text] [Related]
9. Healthy human gut phageome.
Manrique P; Bolduc B; Walk ST; van der Oost J; de Vos WM; Young MJ
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10400-5. PubMed ID: 27573828
[TBL] [Abstract][Full Text] [Related]
10. Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis.
Naseri M; Houri H; Yadegar A; Asadzadeh Aghdaei H; Zahiri J
Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1435-1441. PubMed ID: 34632902
[TBL] [Abstract][Full Text] [Related]
11. Multimodal deep learning applied to classify healthy and disease states of human microbiome.
Lee SJ; Rho M
Sci Rep; 2022 Jan; 12(1):824. PubMed ID: 35039534
[TBL] [Abstract][Full Text] [Related]
12. Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease.
Ghosh TS; Arnoux J; O'Toole PW
Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 32985923
[TBL] [Abstract][Full Text] [Related]
13. Metagenomics Biomarkers Selected for Prediction of Three Different Diseases in Chinese Population.
Wu H; Cai L; Li D; Wang X; Zhao S; Zou F; Zhou K
Biomed Res Int; 2018; 2018():2936257. PubMed ID: 29568746
[TBL] [Abstract][Full Text] [Related]
14. MICROBIOME. Microbial growth dynamics and human disease.
Segre JA
Science; 2015 Sep; 349(6252):1058-9. PubMed ID: 26339017
[No Abstract] [Full Text] [Related]
15. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.
Roderburg C; Luedde T
Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881
[TBL] [Abstract][Full Text] [Related]
16. Subtractive assembly for comparative metagenomics, and its application to type 2 diabetes metagenomes.
Wang M; Doak TG; Ye Y
Genome Biol; 2015 Nov; 16():243. PubMed ID: 26527161
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.
Heidrich B; Vital M; Plumeier I; Döscher N; Kahl S; Kirschner J; Ziegert S; Solbach P; Lenzen H; Potthoff A; Manns MP; Wedemeyer H; Pieper DH
Liver Int; 2018 Jan; 38(1):50-58. PubMed ID: 28561276
[TBL] [Abstract][Full Text] [Related]
19. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes.
Labbé A; Ganopolsky JG; Martoni CJ; Prakash S; Jones ML
PLoS One; 2014; 9(12):e115175. PubMed ID: 25517115
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and obesity: lessons from the microbiome.
Cani PD
Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
